The safety, tolerability and preliminary efficacy of pd-l1 monoclonal antibody combined with lenalidomide in third-line post-treatment of patients with microsatellite stable advanced colorectal cancer: a phase I clinical stud
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2691549
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: single arm:Pd-l1 monoclonal antibody and lenalidomide
Primary outcome(s): Security;Tolerance
Study Design: Single arm
创建时间：
2020-03-15
